Market Closed -
Japan Exchange
01:30:00 2025-01-20 am EST
5-day change
1st Jan Change
4,560.00 JPY
-0.98%
-2.56%
-6.84%
Noevir Holdings Co., Ltd. announces an Equity Buyback for 1,500,000 shares, representing 4.23% for ¥11,000 million.
November 07, 2017 at 01:00 am EST
Noevir Holdings Co., Ltd. (TSE:4928) announces a share repurchase program. Under the program, the company will repurchase up to 1,500,000 shares, representing 4.23% of its share capital, for ¥11,000 million. The company will repurchase its shares in order to enhance shareholder returns along with improving capital efficiency. The share repurchase program will run until November 17, 2017. As of October 31, 2017, the company had 35,451,623 shares outstanding (excluding treasury shares) and 30 shares in treasury.
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2025
Nov. 08
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024
23-11-07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024
23-08-07
CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023
23-05-10
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023
23-05-10
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
23-02-07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
22-11-10
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022
22-08-04
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022
22-05-11
CI
Noevir Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending March 2022 and for the Year Ending September 2022
22-02-08
CI
FACTBOX-Japanese companies opening COVID-19 vaccination sites amid slow national rollout
21-06-04
RE
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. from Takashi Okura.
20-08-02
CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending September 30, 2019
19-08-13
CI
Noevir Holdings Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2018; Provides Earnings Forecast for the Half Year of the Fiscal Year Ending Sept. 30, 2019; Provides Earnings Forecast for the Full Year of the Fiscal Year Ending Sept. 30, 2019; Provides Dividend Forecast for the Fourth Quarter of Fiscal Year Ending Sept. 30, 2019
19-02-11
CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Year Ended September 30, 2018; Provides Earnings Guidance for the Half Year and Year Ending September 30, 2019
18-11-19
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2018; Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2018
18-08-12
CI
Noevir Holdings Co., Ltd.(TSE:4928) added to FTSE All-World Index
18-03-19
CI
Noevir Holdings Co., Ltd.(TSE:4928) added to FTSE All-World Index
18-03-19
CI
Noevir Holdings Co., Ltd. Announces Unaudited Earnings Results for the Three Months Ended December 31, 2017; Provides Earnings Guidance for the Half Year and Full Year for the Fiscal Year Ended September 30, 2018
18-01-31
CI
Tranche Update on Noevir Holdings Co., Ltd.'s Equity Buyback Plan announced on November 7, 2017.
17-11-08
CI
Noevir Holdings Co., Ltd.'s Equity Buyback announced on November 7, 2017 has expired with 1,295,000 shares for ¥9,971.5 million.
17-11-08
CI
Noevir Holdings Co., Ltd. announces an Equity Buyback for 1,500,000 shares, representing 4.23% for ¥11,000 million.
17-11-07
CI
Noevir Holdings Co., Ltd. authorizes a Buyback Plan.
17-11-06
CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Full Year Ended September 30, 2017; Provides Consolidated Earnings Guidance for the First Half and Full Year Ending September 30, 2018; Announces Year-End Dividend for the Year Ended September 30, 2017, Payable on December 8, 2017; Provides Dividend Guidance for the Year Ending September 30, 2018
17-11-06
CI
Noevir Holdings Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending September 30, 2017
17-07-31
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
4928: Dynamic Chart
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
More about the company
Last Close Price
4,605.00 JPY
Average target price
5,100.00 JPY
Spread / Average Target
+10.75%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1